Generic Orap Availability
Last updated on Jun 11, 2025.
Orap is a brand name of pimozide, approved by the FDA in the following formulation(s):
ORAP (pimozide - tablet;oral)
-
Manufacturer: TEVA
Approval date: July 31, 1984
Strength(s): 2MG (discontinued) [RLD] -
Manufacturer: TEVA
Approval date: August 27, 1997
Strength(s): 1MG (discontinued) [RLD]
All of the above formulations have been discontinued.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Orap. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: Generic Drug FAQ.
More about Orap (pimozide)
- Orap consumer information
- Check interactions
- Compare alternatives
- Reviews (17)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antipsychotic agents
- Breastfeeding
Related treatment guides
Related/similar drugs
Abilify
Abilify is an antipsychotic medicine used to treat the symptoms of schizophrenia and bipolar ...
Haldol
Haldol is used for dementia, ICU Agitation, mania, nausea/vomiting, psychosis, tourette's syndrome
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Abilify Maintena
Abilify Maintena (aripiprazole) is an atypical antipsychotic used to treat schizophrenia and ...
Aristada
Aristada (aripiprazole) is an antipsychotic medication. It works by changing the actions of ...
Haldol Decanoate
Haldol Decanoate is used for dementia, ICU Agitation, mania, nausea/vomiting, psychosis, tourette's ...
Abilify Asimtufii
Abilify Asimtufii is used for the treatment of schizophrenia and bipolar I disorder, Abilify ...
Abilify Discmelt
Abilify Discmelt is used for agitated state, autism, bipolar disorder, depression, major depressive ...
Haloperidol
Haloperidol is used for aggressive behavior, borderline personality disorder, dementia, ICU ...
Glossary
| Term | Definition |
|---|---|
| Drug Patent | A drug patent is assigned by the U.S. Patent and Trademark Office and assigns exclusive legal right to the patent holder to protect the proprietary chemical formulation. The patent assigns exclusive legal right to the inventor or patent holder, and may include entities such as the drug brand name, trademark, product dosage form, ingredient formulation, or manufacturing process A patent usually expires 20 years from the date of filing, but can be variable based on many factors, including development of new formulations of the original chemical, and patent infringement litigation. |
| Drug Exclusivity | Exclusivity is the sole marketing rights granted by the FDA to a manufacturer upon the approval of a drug and may run simultaneously with a patent. Exclusivity periods can run from 180 days to seven years depending upon the circumstance of the exclusivity grant. |
| RLD | A Reference Listed Drug (RLD) is an approved drug product to which new generic versions are compared to show that they are bioequivalent. A drug company seeking approval to market a generic equivalent must refer to the Reference Listed Drug in its Abbreviated New Drug Application (ANDA). By designating a single reference listed drug as the standard to which all generic versions must be shown to be bioequivalent, FDA hopes to avoid possible significant variations among generic drugs and their brand name counterpart. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
